Current issues come under the spotlight at The Applied Clinical Trials European Summit 2006
The complex regulations and procedures which govern the running of clinical trials are in the spotlight now, more than ever before. Delegates at the Applied Clinical Trials European Summit, 17 – 19 October 2006, will hear the latest perspectives on a range of highly topical issues from some of the most respected professionals in the field.
Safety remains the overriding priority in clinical development, and to gain a clean bill of health it is vital to have an intimate knowledge of the new regulations and requirements of authorities, as well as an understanding of the relationships between trial partners throughout the development cycle. In the plenary session on Wednesday 19th October, delegates at the ACT Summit 2006 will hear professionals from across Europe discuss Improving drug safety and public health by rigorous pharmacovigilance. Other plenary sessions will deal with regulatory updates, outsourcing strategies and challenges at investigative sites.
In a series of interactive workshops, delegates will have the opportunity to delve into more specific topics in clinical trials. In Making progress in biotechnology trials, delegates will learn about the requirements and approaches of authorities on biotech studies, the impact of EU Clinical Trials Directive, and will hear an overview of immunogenicity, monoclonals, and comparability and biosimilars. Better trial methodology and design will demystify the theory and practice in the new approaches, including adaptive designs. Ten additional workshops cover diverse topics ranging from Positive and consistent outcomes from ethics committees to The complexities of fraud and scientific misconduct.
Running alongside the conference is an exclusive exhibition. The exhibitor list includes: Almac Clinical Service, Cambridge Neurotechnology, Chiltern International, Clinical Systems Ltd, ClinPhone Group Ltd, Creapharm, CRF Inc, CRL Medinet, Datatrial, Dr. Oestreich + Partner GmbH, Fisher Clinical Services, Fulcrum Pharma Developments Ltd, Fundacion Cardiovascular de Colombia, i3 Research (an Ingenix Company), i3 Statprobe (an Ingenix company), Kayentis, LCG Bioscience, MS Pharma Services, Medifacts International, NSD Labelling Group, PAREXEL International, Phase Forward Europe Ltd, QuickStat, Synexus Clinical Research plc and TNT Express.
For delegate information, contact Catherine Mealor on +44 (0) 1244 393422 or email email@example.com.
Notes to Editors:
Advanstar Communications Inc. (www.advanstar.com) is a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries. Advanstar serves business professionals and consumers in these industries with its portfolio of 85 events, 55 publications and directories, 75 electronic publications and websites, as well as educational and direct marketing products and services. Market leading brands and a commitment to delivering innovative, quality products and services enables Advanstar to “Connect Our Customers With Theirs.” Advanstar has roughly 1,000 employees and currently operates from multiple offices in North America and Europe.
Applied Clinical Trials European Summit 2006: 17 – 19 October, The Hilton Netherlands, Amsterdam
For information on exhibiting opportunities or visitor / delegate places, please contact Catherine Mealor, Tel +44 (0) 1244 393422 or email firstname.lastname@example.org
- Contact Information
- Claire King
- Marketing Assistant
- Advanstar Communications
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.